It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2011-2012. During the financial year, The Company’s revenues increased by 30% to Rs. 96,737 million that is $2.02 billion in FY2012 from Rs. 74,693 million in FY2011. EBITDA increased by 51% to Rs. 25,409 million in FY2012 from Rs. 16,789 million in FY2011. Net profit of Rs. 14,262 million in FY2012 from Rs. 11,040 million in FY2011, a growth of 29%. Fully diluted earnings per share increased to Rs. 83.8 in FY2012 from Rs. 65 in FY2011, a growth of 29%.
The Board of Directors of the Company has proposed a dividend of Rs. 13.75 per share (275%) on equity shares of Rs. 5/- each. The dividend, if declared by the shareholders at the 28th Annual General Meeting scheduled on 20th July 2012, will be paid on or after 27th July 2012.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
